IP Verse

Agent For Use In Treatment Or Prevention Of Ophthalmic Disorders - EP4031117

The patent EP4031117 was granted to Chiesi Farmaceutici on Jul 24, 2024. The application was originally filed on Sep 15, 2020 under application number EP20775227A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4031117

CHIESI FARMACEUTICI
Application Number
EP20775227A
Filing Date
Sep 15, 2020
Status
Granted And Under Opposition
Jun 20, 2024
Grant Date
Jul 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANApr 23, 2025HOFFMANN EITLEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2018086805
DESCRIPTIONWO0022119
DESCRIPTIONWO2008006893
DESCRIPTIONWO2013092776
DESCRIPTIONWO2016162812
INTERNATIONAL-SEARCH-REPORTWO2008006893
INTERNATIONAL-SEARCH-REPORTWO2013092776
OPPOSITIONUS5272135
OPPOSITIONUS6090781
OPPOSITIONWO2008006893
OPPOSITIONWO2021052926

Non-Patent Literature (NPL) Citations (45) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BOCCHINI et al., Pro.c Natl. Acad. Sci. USA, (19690000), vol. 64, pages 787 - 794-
DESCRIPTION- DELLA SETA et al., Pharmacol. Biochem. Behav., (19940000), vol. 49, page 701-
DESCRIPTION- DE PETROCELLIS et al., Pharmacol. Res., (20100000), vol. 63, pages 294 - 299-
DESCRIPTION- D'ONOFRIO et al., PLoS One, (20110000), vol. 6, page e20839-
DESCRIPTION- DYCK et al., Neurology, (19970000), vol. 48, pages 501 - 505-
DESCRIPTION- ENG et al., Anal. Chem., (19970000), vol. 69, pages 4184 - 4190-
DESCRIPTION- GARCIA et al., Cytokin Groth Fact. Rev., (20160000), vol. 34, pages 1359 - 1601-
DESCRIPTION- LEVI-MONTALCINI, Progress in Brain Research, (20040000), vol. 146, pages 525 - 527-
DESCRIPTION- LEVIN et al., Progr. Retin. Eye Res., (20020000), vol. 21, pages 465 - 484-
DESCRIPTION- LEWIN et al., Eur. J. Neurosci., (19940000), vol. 6, pages 1903 - 1912-
DESCRIPTION- LUIZ et al., Neuropeptides, (20100000), vol. 44, pages 87 - 92-
DESCRIPTION- MALERBA et al., PlosOne, (20150000), vol. 10, no. 9, page e0136425-
DESCRIPTION- MALERBA et al., PLOS One, (20150000), vol. 10, page e0136425-
DESCRIPTION- MCARTHUR et al., Neurology, (20000000), vol. 54, pages 1080 - 1088-
DESCRIPTION- MESENTIER-LOURO et al., Int. J. Mol. Sci., (20170000), vol. 18, no. 98-
DESCRIPTION- MESENTIER-LOURO et al., Mol. Neurobiol., (20180000), vol. 56, pages 1056 - 1069-
DESCRIPTION- MESENTIER-LOURO et al., Mol. Neurobiol., (20190000), vol. 56, pages 1056 - 1069-
DESCRIPTION- RATTENHOLL et al., Eur. J. Biochem, (20010000), vol. 268, pages 3296 - 3303-
DESCRIPTION- RUIZ et al., Brain Res., (20040000), vol. 1011, pages 1 - 6-
DESCRIPTION- SVENSSON et al., Pain, (20030000), vol. 104, pages 241 - 247-
DESCRIPTION- TREVISAN et al., Brain, (20160000), vol. 139, no. 5, pages 1361 - 1377-
DESCRIPTION- "UniProt", Database accession no. P01139-
DESCRIPTION- VOS et al., J. Neurosci., (19940000), vol. 14, pages 2708 - 2723-
DESCRIPTION- WIESMANN et al., Nature, (19990000), vol. 401, pages 184 - 188-
INTERNATIONAL-SEARCH-REPORT- Y. BAI ET AL, "Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75NTR Activity Is Neurotoxic through a Paracrine Mechanism", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20101013), vol. 285, no. 50, doi:10.1074/jbc.M110.147801, ISSN 0021-9258, pages 39392 - 39400, XP055340264 [A] 1-20 * the whole document *
INTERNATIONAL-SEARCH-REPORT- SALLY L. ELSHAER ET AL, "Pronerve Growth Factor Induces Angiogenesis via Activation of TrkA: Possible Role in Proliferative Diabetic Retinopathy", JOURNAL OF DIABETES RESEARCH, (20130101), vol. 2013, doi:10.1155/2013/432659, ISSN 2314-6745, pages 1 - 10, XP055662833 [A] 1-20 * the whole document *
INTERNATIONAL-SEARCH-REPORT- FRANCESCA MALERBA ET AL, "Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications", PLOS ONE, (20150915), vol. 10, no. 9, doi:10.1371/journal.pone.0136425, page e0136425, XP055310595 [I] 20 * figure 11 * [A] 1-19
OPPOSITION- D2 - Applicant/Proprietor’s submission dated 25 October 2022-
OPPOSITION- D8 - Applicant/Proprietor’s submission dated 23 November 2023-
OPPOSITION- Felix Oehme, J.Peters, "Mixed-Mode Chromatography in Downstream Process Development - Process Development Forum", Bio Pharma International, (20111215), pages 1 - 6, XP055374464-
OPPOSITION- Li Yan, Cassandra L Schlamp, Robert W. Nickells, "Experimental Induction of Retinal Ganglion Cell Death in Adult Mice", IOVS, (19990401), vol. 40, no. 5, pages 1004 - 1008, XP093272285-
OPPOSITION- Weinreb Robert N., Aung Tin, Medeiros Felipe A., "The Pathophysiology and Treatment of Glaucoma : A Review", JAMA, Clyancourt Corporation, Chicago, IL, Chicago, IL, (20140514), vol. 311, no. 18, doi:10.1001/jama.2014.3192, ISSN 0098-7484, page 1901, XP093249035
OPPOSITION- Mesentier-Louro Louise A.; Rosso Pamela; Carito Valentina; Mendez-Otero Rosalia; Santiago Marcelo F.; Rama Paolo; Lambiase Alessandro; Tirassa Paola, "Nerve Growth Factor Role on Retinal Ganglion Cell Survival and Axon Regrowth: Effects of Ocular Administration in Experimental Model of Optic Nerve Injury", Molecular Neurobiology, Springer US, New York, New York, (20180604), vol. 56, no. 2, doi:10.1007/s12035-018-1154-1, ISSN 0893-7648, pages 1056 - 1069, XP036719503
OPPOSITION- Cattaneo Antonino, Capsoni Simona, "Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells", Pharmacological Research, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20190101), vol. 139, doi:10.1016/j.phrs.2018.10.028, ISSN 1043-6618, pages 17 - 25, XP093272310
OPPOSITION- Goldblum David, Mittag Thom, "Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye", Vision Research, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20020201), vol. 42, no. 4, doi:10.1016/S0042-6989(01)00194-8, ISSN 0042-6989, pages 471 - 478, XP093272288
OPPOSITION- Pau D, Al Zubidi N, Yalamanchili S, Plant G T, Lee A G, "Optic neuritis", EYE, Nature Publishing Group, GB, GB , (20110701), vol. 25, no. 7, doi:10.1038/eye.2011.81, ISSN 0950-222X, pages 833 - 842, XP093272290
OPPOSITION- A. Lambiase, Et Al., "Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma", Proceedings of the National Academy of Sciences (PNAS), National Academy of Sciences, (20090811), vol. 106, no. 32, doi:10.1073/pnas.0906678106, ISSN 0027-8424, pages 13469 - 13474, XP055601346
OPPOSITION- Palmer Edward, Gale Jesse, Crowston Jonathan G., Wells Anthony P., "Optic Nerve Head Drusen: An Update", Neuro-Ophthalmology, Informa Healthcare, GB, GB , (20181102), vol. 42, no. 6, doi:10.1080/01658107.2018.1444060, ISSN 0165-8107, pages 367 - 384, XP093272297
OPPOSITION- Falsini Benedetto, Chiaretti Antonio, Rizzo Daniela, Piccardi Marco, Ruggiero Antonio, Manni Luigi, Soligo Marzia, Dickmann Anna, Federici Matteo, Salerni Annabella, Timelli Laura, Guglielmi Gaspare, Lazzareschi Ilaria, Caldarelli Massimo, Galli-Resta Lucia, Colosimo Cesare, Riccardi Riccardo, "Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial", Brain, Oxford University Press, GB, GB , (20160201), vol. 139, no. 2, doi:10.1093/brain/awv366, ISSN 0006-8950, pages 404 - 414, XP093272309
OPPOSITION- Lambiase Alessandro, Tirassa Paola, Micera Alessandra, Aloe Luigi, Bonini Stefano, "Pharmacokinetics of Conjunctivally Applied Nerve Growth Factor in the Retina and Optic Nerve of Adult Rats", Investigative Opthalmology & Visual Science, Association for Research in Vision and Ophthalmology, US, US , (20051001), vol. 46, no. 10, doi:10.1167/iovs.05-0301, ISSN 1552-5783, page 3800, XP093272308
OPPOSITION- Guy Lenaers;Christian Hamel;Cécile Delettre;Patrizia Amati-Bonneau;Vincent Procaccio;Dominique Bonneau;Pascal Reynier;Dan Milea , "Dominant optic atrophy", Orphanet Journal of Rare Diseases, BioMed Central Ltd, Lo, Lo , (20120709), vol. 7, no. 1, doi:10.1186/1750-1172-7-46, ISSN 1750-1172, page 46, XP021129685
OPPOSITION- Francesca Malerba, Francesca Paoletti, Bruno Bruni Ercole, Serena Materazzi, Romina Nassini, Elisabetta Coppi, Riccardo Patacchini, Simona Capsoni, Doriano Lamba, Antonino Cattaneo, "Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a “Painless” Lead Investigational Candidate for Therapeutic Applications", PLOS ONE, vol. 10, no. 9, doi:10.1371/journal.pone.0136425, page e0136425, XP055310588
OPPOSITION- Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C, "Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section", THE JOURNAL OF NEUROSCIENCE, Society for Neuroscience, US, US , (19890401), vol. 9, no. 4, doi:10.1523/JNEUROSCI.09-04-01263.1989, ISSN 0270-6474, pages 1263 - 1272, XP093272307
OPPOSITION- Alessandro Lambiase, Marta Sacchetti, "Diagnosis and management of neurotrophic keratitis", Clinical Ophthalmology, doi:10.2147/OPTH.S45921, page 571, XP055367243
OPPOSITION- Binning Mandy J., Liu James K., Kestle John R. W., Brockmeyer Douglas L., Walker Marion L., "Optic pathway gliomas: a review", Neurosurgical Focus, American Association of Neurological Surgeons, United States, United States , (20071101), vol. 23, no. 5, doi:10.3171/FOC-07/11/E2, ISSN 1092-0684, page E2, XP093272298

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents